Search…

Jiudian Pharmaceuticals: It is expected that the annual revenue in 2025 will increase by 10% - 20% compared to the previous year.

07/08/2025

Jiudian Pharmaceuticals, when receiving institutional research, stated that the company's business revenue for the year 2025 is expected to increase by 10% to 20% year-on-year, and the non-net profit is expected to increase by 10% to 20% year-on-year.

Latest

1 m ago

According to reports, Huayan Robotics is seeking to have an IPO in Hong Kong, raising over $200 million.

3 m ago

Hubei: Vigorously promote the integrated development of domestic and foreign trade, and create a new highland of opening up in inland areas.

3 m ago

The trading volume of Northern Rare Earth reached 10 billion yuan, now up 5.57%.

4 m ago

Rare earth permanent magnet plates continue to rise further, Zhenghai Magnetic Material Co., Ltd. rose by the daily limit of 20CM, Ningbo Yunsheng rose by the daily limit previously. Benlang New Materials, Sanchuan Intelligent, China Magnetic Industry, Longci Technology, and Jiuwugaoke were among the top gainers.

5 m ago

Hema Grocery store clarifies rumors of closing stores: Only 2% of stores will have business adjustments, will open 100 new stores this year, and total number of stores will exceed 500.

See all latest